OWP
IGMS

Old Well Partners’s IGM Biosciences IGMS Stock Holding History

Old Well Partners’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,619
Closed -$218K – 46
2021
Q2 		$218K Hold
2,619
– – 0.1% 30
2021
Q1 		$201K Hold
2,619
– – 0.1% 38
2020
Q4 		$231K Buy
+2,619
New +$184K 0.12% 34

Other funds holding IGMS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Old Well Partners's IGMS Position: Q3 2021 in Review

Old Well Partners sold out of IGM Biosciences (IGMS) in Q3 2021, closing a stake of 2,619 shares — an estimated $218K sold.

Old Well Partners first reported a position in IGMS in Q4 2020 and held it in 3 quarters. The position peaked at $231K in Q4 2020. 107 funds tracked by Wall St. Rank hold IGMS as of Q3 2021.

  • Old Well Partners reported no remaining IGM Biosciences position as of Q3 2021 after selling out during the quarter.
  • Old Well Partners sold 2,619 IGM Biosciences shares in Q3 2021, an estimated $218K.
  • Old Well Partners first reported a position in IGM Biosciences in Q4 2020 and held it in 3 quarters.
  • Old Well Partners's IGM Biosciences position peaked at $231K in Q4 2020.
  • 107 funds tracked by Wall St. Rank held IGM Biosciences as of Q3 2021.

Based on Old Well Partners's 13F filing for Q3 2021, filed 15 Nov 2021.